The Antioxidant Effect of Erythropoietin on Thalassemic Blood Cells
Because of its stimulating effect on RBC production, erythropoietin (Epo) is used to treat anemia, for example, in patients on dialysis or on chemotherapy. In β-thalassemia, where Epo levels are low relative to the degree of anemia, Epo treatment improves the anemia state. Since RBC and platelets of...
Saved in:
Main Authors: | Johnny Amer, Mutaz Dana, Eitan Fibach |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Anemia |
Online Access: | http://dx.doi.org/10.1155/2010/978710 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thalassemic DNA-Containing Red Blood Cells Are under Oxidative Stress
by: Mutaz Dana, et al.
Published: (2012-01-01) -
Study of Frequency and Characteristics of Red Blood Cell Alloimmunization in Thalassemic Patients: Multicenter Study from Palestine
by: Adham Abu Taha, et al.
Published: (2019-01-01) -
Uptake of Non-Transferrin Iron by Erythroid Cells
by: Eugenia Prus, et al.
Published: (2011-01-01) -
Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients
by: Pandji Irani Fianza, et al.
Published: (2021-01-01) -
Erythrocytes and Erythropoietin
by: Michael Föller, et al.
Published: (2011-01-01)